Physician profile
Caroline Flint
NPI 1164743225
$645.54
in general payments reported to CMS, 2019-2025
15 companies · $24.10 in 2025
The $24.10 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $254 · 2020: $13.27 · 2022: $225 · 2023: $113 · 2024: $16.77 · 2025: $24.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $161.86 | 2022-2023 | Nexplanon |
| Pfizer INC. | $88.51 | 2019-2024 | |
| Abbvie INC. | $86.11 | 2019-2023 | |
| Hologic Sales and Service, LLC | $56.20 | 2019-2023 | Myosure Tissue Removal Device, Acessa Provu System |
| Merck Sharp & Dohme LLC | $48.72 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $42.83 | 2019 | |
| Innovation Technologies INC | $24.84 | 2023 | Irrisept |
| Becton, Dickinson and Company | $24.10 | 2025 | Bd Max System, Bd Max Instrument |
| Boston Scientific Corporation | $21.03 | 2019 | |
| Ethicon US, LLC | $20.18 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.04 | 2019 | |
| Astellas Pharma US INC | $16.30 | 2023 | Veozah |
| Amgen INC. | $13.31 | 2019 | |
| Therapeuticsmd, INC. | $12.06 | 2019 | |
| Mission Pharmacal Company | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Flint listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.